Malaria drug and vaccine trials in Africa: obstacles and opportunities

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 1, 2008, Pages 7-10

  Lang, T A ^a   Kokwaro, G O ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Africa; Capacity building; Drug development; Malaria; Public private partnerships; Trials; Vaccine development

Indexed keywords

ARTEMISININ; INSECTICIDE; MALARIA VACCINE; NEW DRUG;

AFRICA; BED NET; CHILDHOOD DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE SEVERITY; DRUG SAFETY; FUNDING; GOOD CLINICAL PRACTICE; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; MALARIA; MORTALITY; PUBLIC HEALTH; REVIEW; SUSTAINABLE DEVELOPMENT;

ADULT; AFRICA; ANTIMALARIALS; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALARIA VACCINES;

EID: 36549000670     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.08.008     Document Type: Review

References (14)

1. Aide P., Bassat Q., and Alonso P.L. Towards an effective malaria vaccine. Arch. Dis. Child. 92 (2007) 476-479
2. Ballou W.R. Malaria vaccines in development. Expert Opin. Emerg. Drugs 10 (2005) 489-503
3. Breman J.G., Alilio M.S., and Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg. 71 (2004) 1-15
4. Bundred P.E., and Levitt C. Medical migration: who are the real losers?. Lancet 356 (2000) 245-246
5. Croft S.L. Public-private partnership: from there to here. Trans. R. Soc. Trop. Med. Hyg. 99 Suppl. 1 (2005) S9-S14
6. Greenwood B. Malaria vaccines. Evaluation and implementation. Acta Trop. 95 (2005) 298-304
7. ICH, 1996. Good Clinical Practice: consolidated guideline. ICH Harmonised Tripartite Guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva. http://www.ich.org/ [accessed 8 August 2007].
8. Kilama W.L. Malaria vaccines in Africa. Acta Trop. 88 (2003) 153-159
9. Lang T., and Greenwood B. The development of Lapdap, an affordable new treatment for malaria. Lancet Infect. Dis. 3 (2003) 162-168
10. MMV, 2006. Portfolio 3rd Q 2006. Medicines for Malaria Venture, Geneva. http://www.mmv.org/IMG/pdf/Portfolio_2006_3Q-V4_3_.pdf [accessed 8 August 2007].
11. MVI, 2006. Development Projects. Malaria Vaccine Initiative, Bethesda, MD. http://www.malariavaccine.org/ab-current_projects.htm [accessed 8 August 2007].
12. Snow R.W., Craig M., Deichmann U., and Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. World Health Organ. 77 (1999) 624-640
13. Trouiller P., and Olliaro P.L. Drug development output: what proportion for tropical diseases?. Lancet 354 (1999) 164
14. White N.J. Developing drugs for neglected diseases. Trop. Med. Int. Health 11 (2006) 383-384